需要在亚洲和大洋洲为mopox采取预防性控制策略
Gregory Gan1, A Janhavi1, Guan Tong1
1Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
Infectious Disease Modelling
|January 31, 2024
概括
对与男性发生性关系的男性 (MSM) 进行预防性疫苗接种可以显著减少亚洲和大洋洲的mpox疫情. 接种疫苗可以将感染率从近90%降至3.1%的水平,并延迟流行病峰值.
科学领域:
- 流行病学 流行病学
- 公共卫生 公共卫生
- 传染病建模 传染病建模
背景情况:
- 最近的mopox疫情揭示了对新型性传播感染 (STIs) 的反应存在差距,特别是在亚洲和大洋洲.
- 亚洲和大洋洲被确定为易受感染的地区,需要强大的基础设施来快速应对性传播感染爆发.
研究的目的:
- 模拟亚洲和大洋洲的mopox疫情.
- 为与男性发生性关系的男性 (MSM) 社区提出预防性疫苗接种策略.
- 评估疫苗在预防或抑制mopox疫情的有效性.
主要方法:
- 利用数据驱动的,异构的性接触网络来模拟新加坡,香港和悉尼的mopox疫情.
- 采用基于个人的SEIR分区模型来模拟流行病轨迹.
- 评估了不同接种疫苗对疫情抑制的影响.
主要成果:
- 模拟显示,在密集的网络 (新加坡,悉尼) 中出现了快速爆发,感染分别在41日和23日达到峰值,而香港则在77日.
- 如果没有接种疫苗,68.2%-89.7%的MSM人口可能会在一年内被感染.
- 疫苗接种策略将感染率降低至3.1% (范围:3.1%-82.2%) 并将香港的流行病峰值推迟了36-50天,或完全防止了疫情爆发.
结论:
- 极其密集且连接良好的性网络 (65.2%-83.2%与超级传播者相连) 需要紧急干预.
- 强烈建议在首例病例确诊后进行预防性或立即接种疫苗.
- 接种疫苗对于管理mopox疫情和预防医疗保健系统压力至关重要.
相关概念视频
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
525
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
525
Drug Control Governance: Regulatory Bodies and Their Impact
160
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
160


